{"protocolSection":{"identificationModule":{"nctId":"NCT02148588","orgStudyIdInfo":{"id":"201405121"},"organization":{"fullName":"Washington University School of Medicine","class":"OTHER"},"briefTitle":"Peripheral Sensory Input in Central Post Stroke Pain (CPSP)","officialTitle":"How \"Central\" is Central Post-stroke Pain? Investigating the Role of Peripheral Sensory Input in Maintaining Central Pain"},"statusModule":{"statusVerifiedDate":"2018-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2014-08"},"primaryCompletionDateStruct":{"date":"2016-12-15","type":"ACTUAL"},"completionDateStruct":{"date":"2017-01-25","type":"ACTUAL"},"studyFirstSubmitDate":"2014-05-15","studyFirstSubmitQcDate":"2014-05-27","studyFirstPostDateStruct":{"date":"2014-05-28","type":"ESTIMATED"},"resultsFirstSubmitDate":"2018-01-31","resultsFirstSubmitQcDate":"2018-04-30","resultsFirstPostDateStruct":{"date":"2018-05-02","type":"ACTUAL"},"lastUpdateSubmitDate":"2018-04-30","lastUpdatePostDateStruct":{"date":"2018-05-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"simon.haroutounian","investigatorTitle":"Assistant Professor","investigatorAffiliation":"Washington University School of Medicine"},"leadSponsor":{"name":"Washington University School of Medicine","class":"OTHER"},"collaborators":[{"name":"Aarhus University Hospital","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"Prospective, open-label study in 10 patients with Central Post Stroke Pain (CPSP). The study will evaluate the effects of peripheral nerve blockade on spontaneous pain and evoked thermal and mechanical responses in CPSP, and assesses the associated local anesthetic pharmacokinetics."},"conditionsModule":{"conditions":["Central Post Stroke Pain"],"keywords":["Central Post Stroke Pain","Nerve block"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"OTHER","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":8,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Pain testing","type":"EXPERIMENTAL","description":"Completion of NPSI questionnaire\n\nSensory mapping of the affected limb\n\nQuantitative Sensory Testing\n\nPatients will have a peripheral nerve blockade","interventionNames":["Drug: Ultrasound-guided peripheral nerve block with 2% lidocaine"]}],"interventions":[{"type":"DRUG","name":"Ultrasound-guided peripheral nerve block with 2% lidocaine","description":"Patients will have a peripheral nerve blockade with a local anesthetic (lidocaine)\n\nAssessment of spontaneous and evoked pain responses\n\nCompletion of NPSI questionnaire\n\nMapping of the affected limb","armGroupLabels":["Pain testing"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Reduction in Spontaneous Pain Intensity After a Peripheral Nerve Block.","description":"Reduction in spontaneous pain intensity in the painful extremity from baseline to 30 minutes after a peripheral nerve block.Spontaneous pain intensity was measured on 0-10 numerical rating scale (NRS), where 0 represents \"no pain\", and 10 represents \"worst pain imaginable\"","timeFrame":"baseline and 30 minutes"}],"secondaryOutcomes":[{"measure":"Change in the Intensity of Cold Sensation","description":"The intensity of cold sensation (application of roller cooled down to 20 degrees Celsius) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful cold); lower scores represent reduced sensitivity (0=no cold sensation)","timeFrame":"baseline and 30 min"},{"measure":"Change in the Intensity of Warm Sensation","description":"The intensity of warm sensation (application of roller heated up to 40 degrees Celsius) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful hot); lower scores represent reduced sensitivity (0=no warmth sensation)","timeFrame":"baseline and 30 min"},{"measure":"Change in the Intensity of Pinprick Sensation","description":"The intensity of pinprick sensation (application of Semmes-Weinstein monofilament #6.1, \\~100g target force) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful sharp); lower scores represent reduced sensitivity (0=no pricking sensation)","timeFrame":"baseline and 30 min"},{"measure":"Change in the Intensity of Brush Sensation","description":"The intensity of brush sensation (application of SENSELab Brush-05) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful brushing sensation); lower scores represent reduced sensitivity (0=no brushing sensation)","timeFrame":"baseline and 30 min"},{"measure":"Reported Pain/Dysesthesia Descriptors on NPSI Questionnaire","description":"Composite scores on NPSI (Neuropathic Pain Symptom Inventory) questionnaire before and 40 minutes after the peripheral nerve block.\n\nThe NPSI assesses participant ranking of specific neuropathic pain descriptors, each ranked on a 0-10 scale, where 0 represents no burning/squeezing/electric shocks (etc), and 10 represents worst burning/squeezing/electric shocks (etc).\n\nThe scores on individual questions are grouped (averaged) into the three following subscales (each subscale scores ranging from 0 to 10):\n\n* Burning pain\n* Paroxysmal pain\n* Paresthesia/dysesthesia","timeFrame":"baseline and 40 min"}]},"eligibilityModule":{"eligibilityCriteria":"Each subject must meet all of the following criteria:\n\n* Age ≥18;\n* CPSP affecting an upper or a lower limb, in a distribution that may be completely covered by a peripheral nerve block;\n* Patient fulfills all mandatory criteria for CPSP, fulfills at least one supportive criteria, and has definite CPSP by probability grading.\n* Pain duration at least 3 months;\n* Spontaneous pain intensity (average pain in past week) of ≥ 4 on 0-10 Numerical Rating Scale (NRS).\n\nExclusion Criteria\n\nSubjects will not be enrolled if any of the following criteria exist:\n\n* Not giving consent to participate in the study;\n* Significant psychiatric or cognitive impairment;\n* Moderate to severe renal or liver failure;\n* Concomitant treatment with warfarin or other anticoagulants;\n* Pregnancy or lactation.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Simon Haroutounian, PHD","affiliation":"Washington Univesity School of Medicine","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Washington University School of Medicine","city":"Saint Louis","state":"Missouri","zip":"63110","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"8"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"8"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"8"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"51.6","spread":"7.4"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"4"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"4"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"5"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"3"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"}]}]}]},{"title":"Region of Enrollment","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}]},{"title":"Denmark","categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Reduction in Spontaneous Pain Intensity After a Peripheral Nerve Block.","description":"Reduction in spontaneous pain intensity in the painful extremity from baseline to 30 minutes after a peripheral nerve block.Spontaneous pain intensity was measured on 0-10 numerical rating scale (NRS), where 0 represents \"no pain\", and 10 represents \"worst pain imaginable\"","populationDescription":"ITT","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"units on a scale","timeFrame":"baseline and 30 minutes","groups":[{"id":"OG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"}]}],"classes":[{"title":"Baseline pain intensity","categories":[{"measurements":[{"groupId":"OG000","value":"6.5","lowerLimit":"4.3","upperLimit":"7.0"}]}]},{"title":"Pain intensity after the block","categories":[{"measurements":[{"groupId":"OG000","value":"0.0","lowerLimit":"0.0","upperLimit":"0.0"}]}]}]},{"type":"SECONDARY","title":"Change in the Intensity of Cold Sensation","description":"The intensity of cold sensation (application of roller cooled down to 20 degrees Celsius) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful cold); lower scores represent reduced sensitivity (0=no cold sensation)","populationDescription":"The entire cohort","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"units on a scale","timeFrame":"baseline and 30 min","groups":[{"id":"OG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"}]}],"classes":[{"title":"Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"7","lowerLimit":"4.5","upperLimit":"7.8"}]}]},{"title":"30 min after the block","categories":[{"measurements":[{"groupId":"OG000","value":"0.0","lowerLimit":"0.0","upperLimit":"1.5"}]}]}]},{"type":"SECONDARY","title":"Change in the Intensity of Warm Sensation","description":"The intensity of warm sensation (application of roller heated up to 40 degrees Celsius) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful hot); lower scores represent reduced sensitivity (0=no warmth sensation)","populationDescription":"The entire cohort","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"units on a scale","timeFrame":"baseline and 30 min","groups":[{"id":"OG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"}]}],"classes":[{"title":"Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"1.4"}]}]},{"title":"30 min after the block","categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"1.1"}]}]}]},{"type":"SECONDARY","title":"Change in the Intensity of Pinprick Sensation","description":"The intensity of pinprick sensation (application of Semmes-Weinstein monofilament #6.1, \\~100g target force) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful sharp); lower scores represent reduced sensitivity (0=no pricking sensation)","populationDescription":"The entire cohort","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"units on a scale","timeFrame":"baseline and 30 min","groups":[{"id":"OG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"}]}],"classes":[{"title":"Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"5.0","spread":"2.1"}]}]},{"title":"30 min after block","categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.2"}]}]}]},{"type":"SECONDARY","title":"Change in the Intensity of Brush Sensation","description":"The intensity of brush sensation (application of SENSELab Brush-05) was measured on 0-10 scale, where 5 represents \"normal\" sensation (comparable to contralateral non-painful extremity). Higher scores indicate increased sensitivity (10= painful brushing sensation); lower scores represent reduced sensitivity (0=no brushing sensation)","populationDescription":"The entire cohort","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"units on a scale","timeFrame":"baseline and 30 min","groups":[{"id":"OG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"}]}],"classes":[{"title":"Baseline","categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"1.9"}]}]},{"title":"30 min after block","categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Reported Pain/Dysesthesia Descriptors on NPSI Questionnaire","description":"Composite scores on NPSI (Neuropathic Pain Symptom Inventory) questionnaire before and 40 minutes after the peripheral nerve block.\n\nThe NPSI assesses participant ranking of specific neuropathic pain descriptors, each ranked on a 0-10 scale, where 0 represents no burning/squeezing/electric shocks (etc), and 10 represents worst burning/squeezing/electric shocks (etc).\n\nThe scores on individual questions are grouped (averaged) into the three following subscales (each subscale scores ranging from 0 to 10):\n\n* Burning pain\n* Paroxysmal pain\n* Paresthesia/dysesthesia","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"units on a scale","timeFrame":"baseline and 40 min","groups":[{"id":"OG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"}]}],"classes":[{"title":"Burning pain- baseline","categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":"3.7"}]}]},{"title":"burning pain - 40 min after block","categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.0"}]}]},{"title":"paroxysmal pain - baseline","categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"2.1"}]}]},{"title":"Paroxysmal pain - 40 min after block","categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.0"}]}]},{"title":"paresthesia/dysesthesia - baseline","categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"3.3"}]}]},{"title":"paresthesia/dysesthesia - 40 min after block","categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"1.3"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"48 hours","eventGroups":[{"id":"EG000","title":"The Entire Cohort","description":"All participants received a peripheral nerve block","deathsNumAffected":0,"deathsNumAtRisk":8,"seriousNumAffected":0,"seriousNumAtRisk":8,"otherNumAffected":4,"otherNumAtRisk":8}],"otherEvents":[{"term":"Perioral numbness","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Two patients reported perioral numbness for 14 and 10 minutes, respectively. Resolved spontaneously","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":8}]},{"term":"Dizziness","organSystem":"Nervous system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"One subject reported dizziness (for 10 minutes), resolved spontaneously","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":8}]},{"term":"Vasovagal response","organSystem":"Nervous system disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"One patient experienced a vasovagal response during needle placement, but recovered uneventfully, and the study team proceeded with the block 5 minutes thereafter","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":8}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Simon Haroutounian","organization":"Washington University School of Medicine","email":"simon.haroutounian@wustl.edu","phone":"3142861715","phoneExt":"314"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M12756","name":"Pain","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000008012","term":"Lidocaine"}],"ancestors":[{"id":"D000000779","term":"Anesthetics, Local"},{"id":"D000000777","term":"Anesthetics"},{"id":"D000002492","term":"Central Nervous System Depressants"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000018689","term":"Sensory System Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000000889","term":"Anti-Arrhythmia Agents"},{"id":"D000061567","term":"Voltage-Gated Sodium Channel Blockers"},{"id":"D000026941","term":"Sodium Channel Blockers"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M10704","name":"Lidocaine","asFound":"Muscle","relevance":"HIGH"},{"id":"M3797","name":"Anesthetics","relevance":"LOW"},{"id":"M3799","name":"Anesthetics, Local","relevance":"LOW"},{"id":"M3903","name":"Anti-Arrhythmia Agents","relevance":"LOW"},{"id":"M22867","name":"Sodium Channel Blockers","relevance":"LOW"},{"id":"M29715","name":"Diuretics, Potassium Sparing","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnArAg","name":"Anti-Arrhythmia Agents"},{"abbrev":"ChanBlk","name":"Channel Blockers"},{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":true}